"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...

Zydus Lifesciences and Lupin are joining forces. They will make a generic version of the popular weight-loss and diabetes drug semaglutide ...

The Delhi High Court has permitted Zydus Lifesciences to produce and market a biosimilar cancer drug. This decision comes as the patent for...

Indian drugmakers Glenmark, Granules India, Sun Pharma, Zydus, and Unichem are recalling various products in the US market due to manufactu...

Eris Lifesciences announced that its Ahmedabad manufacturing facility secured approval from ANVISA, Brazil's health regulatory agency, foll...

The US Food and Drug Administration (USFDA) conducted the inspection from December 14 to December 22, 2023. The inspection closed with six ...

The NYSE-listed, $2-billion drug maker by sales (2020), which is foraying into India's domestic formulations segment with focus on biologic...

The company has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employe...

Ahmedabad-based drug company, is looking for setting up a SPV for funding innovation done by individual or start-up firms in the field of d...

In MDS, the bone marrow does not make enough healthy blood cells and there are abnormal cells present, leading to leukaemia in advanced sta...

Zameer Agrawal, director, Roselabs Biosciences Ltd, said, "We have recently entered into a $20 million contract supply deal with a Brazilia...

West-Coast Pharmaceuticals will begin with some 40 products from own formulations under the brand name HealthVit.

3 PE firms are vying for a minority stake in generic drugmaker Intas Pharmaceuticals, two people familiar with the development told ET.

Zydus Cadila, Panacea Biotech and Serum Institute have resumed production of the swine flu vaccine as the once-pandemic disease threatens t...

The US drug regulator has inspected the manufacturing plants of at least half-a-dozen Indian drugmakers, raising hopes that these companies...

A series of buyouts by foreign heavy weights, including Ranbaxy and Piramal Healthcare has resulted in foreign MNCs taking three slots amon...

Israeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from sel...